BNP Paribas Upgrades Healthpeak Properties (NYSE:DOC) to “Outperform”

BNP Paribas upgraded shares of Healthpeak Properties (NYSE:DOC) from a neutral rating to an outperform rating in a report released on Friday, MarketBeat reports. The firm currently has $21.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $19.00.

DOC has been the topic of a number of other reports. Mizuho reissued a buy rating and issued a $22.00 target price on shares of Healthpeak Properties in a research note on Monday, April 22nd. Bank of America raised Healthpeak Properties from an underperform rating to a buy rating and increased their target price for the stock from $18.00 to $25.00 in a research note on Monday, April 1st. Royal Bank of Canada increased their target price on Healthpeak Properties from $21.00 to $22.00 and gave the stock an outperform rating in a research note on Wednesday, April 10th. StockNews.com raised Healthpeak Properties from a sell rating to a hold rating in a research report on Friday, April 5th. Finally, Compass Point reduced their price objective on Healthpeak Properties from $19.00 to $18.00 and set a buy rating for the company in a report on Tuesday, January 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of Hold and a consensus price target of $18.36.

Healthpeak Properties Price Performance

DOC opened at $18.82 on Friday. The stock has a fifty day simple moving average of $16.66 and a two-hundred day simple moving average of $13.74. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.00. The company has a market cap of $13.35 billion, a price-to-earnings ratio of 53.77, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. Healthpeak Properties has a 12-month low of $15.24 and a 12-month high of $22.38.

Institutional Investors Weigh In On Healthpeak Properties

Large investors have recently made changes to their positions in the company. Parallel Advisors LLC grew its stake in shares of Healthpeak Properties by 274.6% during the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 2,985 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Healthpeak Properties by 42.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock valued at $70,000 after purchasing an additional 1,712 shares during the period. Quadrant Capital Group LLC grew its stake in shares of Healthpeak Properties by 645.4% during the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 8,352 shares during the period. Stratos Wealth Partners LTD. bought a new stake in shares of Healthpeak Properties during the 4th quarter valued at about $134,000. Finally, Envestnet Portfolio Solutions Inc. bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $124,000. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.